Vericel Corp. (VCEL): On May 10th, 2017, Vericel(VCEL) announc...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	590
Posts	20577
Boards Moderated	0
Alias Born	02/01/2012

lasers

Re: None

Friday, 05/12/2017 9:38:39 AM

Friday, May 12, 2017 9:38:39 AM

On May 10th, 2017, Vericel(VCEL) announced that the US FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation for ixmyelocel-T - an investigational product for the treatment of patients with advanced heart failure due to ischemic dilated cardiomyopathy. The RMAT designation is a new, expedited program established under the 21st Century Cures Act to foster the development and approval of regenerative medicine products intended for the treatment of serious diseases and conditions.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent VCEL News

Form 8-K - Current report • Edgar (US Regulatory) • 05/18/2026 08:05:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:06:59 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:05:15 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 06:16:06 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/11/2026 06:32:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:05:58 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:05:57 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 04:36:16 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 04:02:38 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 12:54:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 11:57:40 AM
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance • GlobeNewswire Inc. • 05/07/2026 11:45:00 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 07:30:18 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:06:06 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:06:04 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:06:04 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:06:03 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:06:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:05:35 PM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 06:34:18 PM
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026 • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 08:05:42 PM
Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid • GlobeNewswire Inc. • 04/02/2026 06:40:00 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/02/2026 06:28:38 PM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/01/2026 11:50:29 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent VCEL News

More VCEL News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent VCEL News

Go Ad-Free